Australia markets close in 3 hours 38 minutes

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0300-0.1600 (-7.31%)
At close: 4:00PM EDT
2.0400 +0.01 (0.49%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.1900
Open2.1200
Bid2.0400 x 1000
Ask2.1300 x 800
Day's range1.9900 - 2.1407
52-week range1.3600 - 9.7600
Volume600,036
Avg. volume1,261,363
Market cap90.526M
Beta (5Y monthly)1.43
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Shares of Acasti Pharma Slumped Tuesday

    Acasti Pharma (NASDAQ: ACST) fell by more than 18% in Tuesday trading. The company said that it had closed its merger with Grace Therapeutics; former Acasti shareholders now own 59% of the combined company. The second -- and more concerning -- part of the announcement was that the company would perform an 8-1 reverse split at the start of trading on Aug. 31.

  • Simply Wall St.

    Acasti Pharma Inc.'s (CVE:ACST) Shift From Loss To Profit

    We feel now is a pretty good time to analyse Acasti Pharma Inc.'s ( CVE:ACST ) business as it appears the company may...

  • Zacks

    Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade

    Acasti (ACST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).